Fatih Mercan


Dr. Fatih Mercan is a patent attorney who advises clients ranging from multinational corporations to startups on a broad range of technologies to align their intellectual property (IP) strategy with their business goals. He is based in the firm’s New York office, where he is a member of the Chemical, Biotechnology & Pharmaceutical Practice.

In addition to drafting and prosecuting patent applications, Fatih assists clients in patent portfolio management, freedom-to-operate, patent invalidity, non-infringement, and IP due diligence matters. He has a deep familiarity with patent law issues specific to life sciences-based technologies, including biochemistry, cell signaling, diagnostics, therapeutics, genetics, immunology, microbiome, and nucleic acids.

Beyond his patent practice at Foley, Fatih is dedicated to supporting pro bono legal opportunities, with a special focus on representing clients seeking asylum under the Violence Against Women Act and those with Special Immigrant Juvenile Status.

Prior to joining Foley, Fatih served as a patent agent at a boutique intellectual property firm in New York, where he drafted and prosecuted patent applications, evaluated the patentability of innovations, conducted prior art database searches for patentability and freedom-to-operate analyses, and analyzed patent and scientific papers and documents.

Before pursuing his legal career, Fatih spent several years working as a postdoctoral fellow at Cold Spring Harbor Laboratory (CSHL) conducting research on cancer epigenetics, specifically related to prostate cancer and leukemia. While at CSHL, Fatih also interned within the lab’s Office of Technology Transfer. Before CSHL, Fatih conducted doctoral research on cell signaling at Yale University, aiming to understand how normal cells sense and respond to nutrients.

Awards and Recognition

  • Morton Wasserman Award (2021)
  • The Wann Family Foundation Award (2021)
  • Dean’s Award in Excellence, St. John’s University School of Law (2021)
  • Michael DeVito Memorial Scholarship, St. John’s University School of Law (2019)
  • Recipient, Dean’s List, St. John’s University School of Law (2017-2021)


  • Member, New York State Bar Association
  • Member, American Bar Association

Presentations and Publications

  • Co-author, “BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia,” Molecular Cell (May 12, 2015)
  • Co-author, “Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation,” Genes & Development (2013)
  • Co-author, “A Novel Role For SHP-2 In Nutrient-Responsive Control of S6 Kinase 1 Signaling,” Molecular and Cellular Biology (2013)
  • Co-author, “MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy,” The FASEB Journal (2010)
  • Co-author, “Analysis of protein tyrosine phosphatases and substrates,” Current Protocols in Molecular Biology, Chapter 18, Unit 18-16 (2010)
  • Co-author, “Role of MKP-1 in osteoclasts and bone homeostasis,” American Journal of Pathology (2009)